help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0862
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/9/3599    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, P. Y.
Right arrow Articles by Handelsman, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, P. Y.
Right arrow Articles by Handelsman, D. J.
Related Collections
Right arrow Male Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 9 3599-3603
Copyright © 2007 by The Endocrine Society


BRIEF REPORT

Age-Related Changes in Serum Testosterone and Sex Hormone Binding Globulin in Australian Men: Longitudinal Analyses of Two Geographically Separate Regional Cohorts

Peter Y. Liu, Jonathan Beilin, Christian Meier, Tuan V. Nguyen, Jacqueline R. Center, Peter J. Leedman, Markus J. Seibel, John A. Eisman and David J. Handelsman

Department of Andrology (P.Y.L., D.J.H.), Concord Hospital and ANZAC Research Institute, University of Sydney, Sydney, New South Wales 2139, Australia; Department of Endocrinology and Diabetes (J.B., P.J.L.), Royal Perth Hospital, Perth 6847, Western Australia, Australia; Bone Research Program (C.M., M.J.S.), ANZAC Research Institute, University of Sydney, Sydney 2006, Australia; Division of Endocrinology, Diabetes, and Clinical Nutrition (C.M.), University Hospital Basel, 4031 Basel, Switzerland; Bone and Mineral Research Program (T.V.N., J.R.C., J.A.E.), Garvan Institute of Medical Research, St. Vincent’s Hospital and University of New South Wales, Sydney 2010, Australia; and Laboratory for Cancer Medicine (P.J.L.), Centre for Medical Research, School of Medicine and Pharmacology, University of Western Australia and the Western Australian Institute for Medical Research, Perth 6000, Australia

Address all correspondence and requests for reprints to: David J. Handelsman, MBBS, Ph.D., FRACP, Department of Andrology, Concord Hospital, ANZAC Research Institute, University of Sydney, Sydney, New South Wales 2139, Australia. E-mail: djh{at}anzac.edu.au.

Background: Cross-sectional studies from different populations show a variable decline in blood testosterone concentrations as men age. Few population representative cohorts have been followed up over time.

Objective: The objective of the study was to quantify longitudinally the change in serum testosterone and SHBG concentrations with age in two well-defined, representative but geographically widely separated regional Australian cohorts.

Subjects and Setting: The Busselton cohort comprises individuals aged 18–90 yr residing in Western Australia assessed prospectively since 1981. Sera were assayed from 910 men, from whom further samples were available 14 yr later in 480. The Dubbo cohort involves individuals aged 61–90 yr living in Eastern Australia. Baseline sera were collected from 610 men and additional sera on a second (n = 370) and third (n = 200) occasion from 1989 to 2004. Men from both cohorts are community dwelling and of predominately European origin.

Results: Longitudinal analyses show the following: 1) total testosterone declines comparably (P > 0.9) by 1.3% (Busselton) and 0.9% (Dubbo) per annum with the same rates of decline when analyses were restricted to men older than 60 yr of age; 2) annual changes in SHBG were also very similar in age-restricted analyses (2.3% vs. 2.5%, P = 0.48); and 3) the annual increase in SHBG was steeper in middle-aged and older men (P < 10–3 vs. young men). These longitudinal changes were all up to 4-fold greater in magnitude, compared with cross-sectional analyses of baseline data.

Conclusion: In two separate regional Australian populations, blood testosterone fell and SHBG increased comparably with age. Age-related changes in blood testosterone and SHBG previously described in urban-dwelling men are the same in men who reside in smaller regional cities of another continent.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society